Real-time enrollment status for this hormone receptor positive early breast cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:44 PM UTC
| NCT Number | NCT07401381 |
| Recruiting Status | Recruiting |
| Condition | Hormone Receptor Positive Early Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Rovi Pharmaceuticals Laboratories |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT07401381 is currently recruiting participants. This phase1 study for hormone receptor positive early breast cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Rovi Pharmaceuticals Laboratories. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07401381 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07401381 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.